000 01558 a2200445 4500
005 20250513140033.0
264 0 _c19980403
008 199804s 0 0 eng d
022 _a0021-5155
024 7 _a10.1016/s0021-5155(97)00083-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIkeda, E
245 0 0 _aTacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis.
_h[electronic resource]
260 _bJapanese journal of ophthalmology
_c
300 _a396-402 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aArrestin
_ximmunology
650 0 4 _aAutoimmune Diseases
_xchemically induced
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Therapy, Combination
650 0 4 _aImmunization
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aInjections, Intraperitoneal
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMale
650 0 4 _aPolyenes
_xtherapeutic use
650 0 4 _aRats
650 0 4 _aRats, Inbred Lew
650 0 4 _aRetinitis
_xchemically induced
650 0 4 _aSirolimus
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTacrolimus
_xtherapeutic use
650 0 4 _aUveitis, Posterior
_xchemically induced
700 1 _aHikita, N
700 1 _aEto, K
700 1 _aMochizuki, M
773 0 _tJapanese journal of ophthalmology
_gvol. 41
_gno. 6
_gp. 396-402
856 4 0 _uhttps://doi.org/10.1016/s0021-5155(97)00083-x
_zAvailable from publisher's website
999 _c9477121
_d9477121